What are the normal thyroid‑stimulating hormone (TSH) and free thyroxine (free T4) reference ranges for children at various ages?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Normal Thyroid Levels in Children

Thyroid hormone reference ranges in children are age-dependent and differ substantially from adult values, requiring age-specific interpretation to avoid misdiagnosis. 1, 2

Age-Specific TSH Reference Ranges

Early Childhood (Ages 2–6 years)

  • TSH: 0.62–5.19 mIU/L 3, 4
  • This range is notably higher than adult values and reflects the physiologic demands of growth and development 5

School Age (Ages 7–12 years)

  • TSH: 0.53–5.16 mIU/L (ages 7–8) 4
  • TSH: 0.62–4.52 mIU/L (ages 9–10) 4
  • TSH: 0.62–3.36 mIU/L (ages 11–12) 4
  • The upper limit progressively declines through this age range 5, 6

Adolescence (Ages 13–17 years)

  • TSH: 0.54–2.78 mIU/L (ages 13–14) 4
  • TSH: 0.32–3.00 mIU/L (age 15) 4
  • Puberty is accompanied by decreased TSH concentrations, with values approaching adult ranges by age 18 7, 5

Age-Specific Free T4 Reference Ranges

Early Childhood (Ages 6 months–6 years)

  • Free T4: 18.0–34.7 pmol/L (1.40–2.70 ng/dL) 8
  • Free T4: 13.09–20.61 pmol/L (1.02–1.60 ng/dL) for ages 4–6 years using different assay methods 3
  • Values are substantially higher than in older children and adults 8, 5

School Age (Ages 7–12 years)

  • Free T4: 14.2–25.7 pmol/L (1.10–2.00 ng/dL) 8
  • Free T4: 0.96–1.61 ng/dL using electrochemiluminescence assays 4
  • A temporary nadir occurs around Tanner stage 3 during puberty 7

Adolescence (Ages 13–17 years)

  • Free T4: 14.2–25.7 pmol/L (1.10–2.00 ng/dL) 8
  • Free T4: 0.95–1.53 ng/dL 4
  • Values stabilize and approach adult ranges by late adolescence 5, 6

Age-Specific Free T3 Reference Ranges

Early Childhood (Ages 6 months–6 years)

  • Free T3: 5.7–13.1 pmol/L (3.7–8.5 pg/mL) 8
  • Free T3: 2.91–5.10 pg/mL using electrochemiluminescence assays 4

School Age (Ages 7–12 years)

  • Free T3: 5.7–10.0 pmol/L (3.7–6.5 pg/mL) 8
  • Free T3: 2.78–4.90 pg/mL 4
  • Boys may show a temporary peak during puberty 7

Adolescence (Ages 13–17 years)

  • Free T3: 4.5–9.4 pmol/L (2.9–6.1 pg/mL) 8
  • Girls: 2.50–4.64 pg/mL; Boys: 2.77–4.59 pg/mL 4
  • Progressive decline toward adult values occurs through adolescence 7, 3

Critical Interpretation Considerations

Assay-Specific Variation

  • Reference ranges vary significantly by immunoassay platform (Roche, Abbott, Siemens, Beckman Coulter), so clinicians must use the specific reference range provided by their laboratory 6
  • Equilibrium dialysis-liquid chromatography-tandem mass spectrometry provides the most accurate measurement but is not widely available 8

Body Mass Index Effects

  • BMI positively correlates with TSH (β = 0.081), with the effect more pronounced in overweight children (β = 0.142) 7
  • BMI positively correlates with free T3 (β = 0.066) and negatively with free T4 (β = -0.135) 7
  • Overweight adolescents have significantly higher TSH levels than normal-weight peers, but free T3 and free T4 remain similar 3

Pubertal Changes

  • Puberty causes decreased TSH and free T3, with a temporary free T4 nadir at Tanner stage 3 in both sexes 7
  • Males may show a temporary free T3 peak during puberty 7
  • These physiologic changes must be considered when interpreting thyroid function during adolescence 7

Common Pitfalls to Avoid

Misapplication of Adult Reference Ranges

  • Using adult reference ranges in children leads to frequent misdiagnosis, including missed subclinical hypothyroidism or false hyperthyroidism diagnoses 2, 4
  • The wide spread of values immediately after birth and rapid changes in the first 2 years make interpretation particularly challenging in infants 5

Incomplete Testing in Suspected Hyperthyroidism

  • Always measure free T3 when TSH is suppressed in children, as approximately 13% of pediatric hyperthyroid patients have T3-predominant disease that would be missed by free T4 alone 2

Biotin Interference

  • Biotin supplementation interferes with streptavidin-biotin immunoassays and can produce false-positive hyperthyroidism results 2
  • Discontinue biotin at least 48 hours before thyroid testing when possible

Sample Timing During Treatment

  • Blood samples must be drawn at least 4 hours after levothyroxine administration to avoid transient TSH suppression 1, 9, 2

Treatment Thresholds for Congenital Hypothyroidism

Immediate Treatment Indications

  • Start levothyroxine immediately when venous free T4 is below age-specific norms 1, 10
  • Start treatment when venous TSH ≥ 20 mIU/L, even if free T4 is normal 1, 10
  • For TSH 6–20 mIU/L beyond 21 days of life with normal free T4, consider imaging and either immediate treatment with later re-evaluation or close monitoring with repeat testing in 2 weeks 1

Target Ranges During Treatment

  • Maintain TSH within the age-specific reference range (avoid undetectable TSH < 0.05 mIU/L) 1, 10
  • Keep free T4 in the upper half of the age-specific reference range, especially during the first 3 years of life 1, 10
  • Do not reduce levothyroxine dose based on a single isolated elevated free T4 measurement 1, 10

References

Guideline

Pediatric Thyroid Testing: Evidence‑Based Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Reference ranges for analytes of thyroid function in children.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2011

Guideline

Guidelines for TSH Monitoring in Levothyroxine Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Congenital Hypothyroidism: Evidence‑Based Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.